医薬品・医療機器組合せ製品の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2024年～2032年）

世界の医薬品・医療機器組合せ製品の市場規模は、2023年の1,446億6,000万米ドルから、2032年には2,967億4,000万米ドル近くに達し、調査期間2024年～2032年のCAGRは8.31%と推定されます。

医薬品・医療機器組合せ製品とは、薬物・生物学的製剤と医療機器を組み合わせ、治療効果をもたらしたり、特定の治療機能を実行したりする医療製品です。これらの製品は、標的を絞ったドラッグデリバリーの提供、薬効の増強、患者のコンプライアンスの改善、あるいは従来の薬物製剤や医療機器だけでは達成できないような新しい治療法の実現などを目的として設計されています。これらの製品には、薬剤溶出ステント、インスリンポンプ、避妊用インプラント、吸入装置など、さまざまなヘルスケア介入が含まれます。これらの革新的な製品は、精密医療、個別化治療、患者の利便性において潜在的な利点を提供し、様々な治療分野における治療の進歩と患者の転帰の改善を促進します。

市場力学

オーダーメイド医療と標的療法に対する需要の高まりは、正確なドラッグデリバリー・メカニズムと患者のコンプライアンス向上を提供する革新的な医薬品・医療機器組合せ製品の開発を後押ししています。医療従事者と患者がより効果的で利便性の高い治療法を求める中、医薬品の治療上の利点と医療機器の精度と信頼性を組み合わせた製品への関心が高まっています。さらに、薬剤製剤技術や機器設計の進歩により、慢性疾患から急性疾患に至るまで、数多くの病状に対応する新規の組合せ製品の開発が可能になっています。さらに、FDAのCombination Product PolicyやEUのMedical Device Regulation（MDR）など、配合剤に関する規制の取り組みやガイドラインは、メーカーが複雑な規制状況を乗り切り、革新的な製品を市場に投入するための枠組みを提供しています。

さらに、製薬企業、医療機器メーカー、研究機関の戦略的提携は、技術革新と医薬品・医療機器組合せ製品の市場開拓を促進し、治療領域にわたる新たな医薬品・医療機器組合せ製品の開発を促進しています。医療費の増大と配合剤に対する償還支援が研究開発への投資を促し、医薬品・医療機器組合せ製品市場の成長をさらに促進します。しかし、配合剤開発に関連する規制上のハードルや複雑さ、償還に関する課題は、今後数年間の医薬品・医療機器組合せ製品市場の成長に影響を与える可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、医薬品・医療機器組合せ製品の世界市場における各セグメントを包括的に評価することもできます。医薬品・医療機器組合せ製品産業の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

本セクションでは、国別および地域別のセグメントに関する詳細なデータを提供することで、戦略担当者がそれぞれの製品またはサービスのターゲット層を特定し、今後のビジネスチャンスに役立てることができます。

地域別分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの地域展望をカバーし、医薬品・医療機器組合せ製品市場の現在と将来の需要を明らかにしています。さらに、すべての主要地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 医薬品・医療機器組合せ製品：産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 業界動向
• ポーターのファイブフォース分析
• 市場の魅力分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 医薬品・医療機器組合せ製品の世界市場分析：製品別

• 製品別の概要
• 実績データと予測データ分析：製品別
• 薬剤溶出ステント（冠動脈薬剤溶出ステント、末梢薬剤溶出ステント）
• 輸液ポンプ（埋め込み型輸液ポンプ、インスリン輸液ポンプ、患者制御鎮痛ポンプ、外来輸液ポンプ、容量型輸液ポンプ、使い捨て輸液ポンプ）
• 光線力学療法
• 創傷ケア組合せ製品
• プレフィルドシリンジ（シングルチャンバー・プレフィルドシリンジ、デュアルチャンバー・プレフィルドシリンジ、カスタマイズ・プレフィルドシリンジ）
• 薬剤溶出性バルーン（冠動脈薬剤溶出性バルーン、末梢薬剤溶出性バルーン）
• ネブライザー
• 吸入器（薬剤粉末吸入器（DPI）、定量吸入器（MDI）、ソフトミスト吸入器（SMI））
• 経皮吸収型製剤（アクティブ経皮吸収型製剤、パッシブ経皮吸収型製剤）
• 整形外科用組合せ製品（骨移植インプラント、抗生物質充填骨セメント）
• 抗菌カテーテル（泌尿器用カテーテル、心臓血管用カテーテル、その他のカテーテル、その他の製品）

第6章 医薬品・医療機器組合せ製品の世界市場分析：用途別

• 用途別の概要
• 実績データと予測データ分析：用途別
• 心血管疾患
• 糖尿病
• 呼吸器疾患
• がん治療
• 抗菌用途
• その他

第7章 医薬品・医療機器組合せ製品の世界市場分析：最終用途別

• 最終用途別の概要
• 実績データと予測データ分析：最終用途別
• 病院および診療所
• 外来手術センター
• 在宅医療
• その他

第8章 医薬品デバイス組み合わせ製品の世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米の売上分析
  • 概要・実績・予測
  • 北米：セグメント別
  • 北米：国別
  • 米国
  • カナダ
  • メキシコ
• 欧州の売上分析
  • 概要・実績・予測
  • 欧州：セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋の売上分析
  • 概要・実績・予測
  • アジア太平洋：セグメント別
  • アジア太平洋：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • 東南アジア
  • その他アジア太平洋
• ラテンアメリカの売上分析
  • 概要・実績・予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他ラテンアメリカ
• 中東・アフリカの売上分析
  • 概要・実績・予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別一覧
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ

第9章 医薬品・医療機器組合せ製品企業の競合情勢

• 医薬品・医療機器組合せ製品市場の競合
• 提携・協力・協定
• 合併・買収
• 新製品発売
• その他の開発

第10章 企業プロファイル

• 上位企業の市場シェア分析
• 市場集中度
• Abbott Laboratories
• AbbVie Inc.
• Alcon Inc.
• Bausch Health Companies Inc
• Baxter International Inc.
• Bayer AG
• Becton, Dickinson And Company
• Teva Pharmaceutical Industries Ltd
• Boston Scientific Corporation
• GlaxoSmithKline Plc
• Johnson & Johnson
• Kaleo Inc.
• Medtronic Plc
• Novartis AG
• Sinomed
• Smith & Nephew Plc
• Teleflex Incorporated

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Market Sales By Geography (USD MN)
• Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Market Sales By Geography (USD MN)
• Photodynamic Therapy Market Sales By Geography (USD MN)
• Wound Care Combination Product Market Sales By Geography (USD MN)
• Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Market Sales By Geography (USD MN)
• Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Market Sales By Geography (USD MN)
• Nebulizers Market Sales By Geography (USD MN)
• Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Market Sales By Geography (USD MN)
• Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Market Sales By Geography (USD MN)
• Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Market Sales By Geography (USD MN)
• Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Cardiovascular Disorders Market Sales By Geography (USD MN)
• Diabetes Market Sales By Geography (USD MN)
• Respiratory Problems Market Sales By Geography (USD MN)
• Cancer Treatment Market Sales By Geography (USD MN)
• Antimicrobial Application Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Analysis By End-use (USD MN)
• Hospitals And Clinics Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Home Care Settings Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Drug Device Combination Products Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Drug Device Combination Products Report
• Market Research Process
• Market Research Methodology
• Global Drug Device Combination Products Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End-use
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Market Sales By Geography (USD MN)
• Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Market Sales By Geography (USD MN)
• Photodynamic Therapy Market Sales By Geography (USD MN)
• Wound Care Combination Product Market Sales By Geography (USD MN)
• Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Market Sales By Geography (USD MN)
• Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Market Sales By Geography (USD MN)
• Nebulizers Market Sales By Geography (USD MN)
• Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Market Sales By Geography (USD MN)
• Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Market Sales By Geography (USD MN)
• Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Market Sales By Geography (USD MN)
• Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Cardiovascular Disorders Market Sales By Geography (USD MN)
• Diabetes Market Sales By Geography (USD MN)
• Respiratory Problems Market Sales By Geography (USD MN)
• Cancer Treatment Market Sales By Geography (USD MN)
• Antimicrobial Application Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Market Analysis By End-use (USD MN)
• Hospitals And Clinics Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Home Care Settings Market Sales By Geography (USD MN)
• Other Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Drug Device Combination Products Market is presumed to reach the market size of nearly USD 296.74 Billion by 2032 from USD 144.66 Billion in 2023 with a CAGR of 8.31% under the study period 2024-2032.

Drug device combination products are medical products that combine a drug or biologic substance with a medical device to deliver therapeutic benefits or perform specific treatment functions. These products are designed to provide targeted drug delivery, enhance drug efficacy, improve patient compliance, or enable novel treatment modalities that may not be achievable with conventional drug formulations or medical devices alone. These products encompass various healthcare interventions, including drug-eluting stents, insulin pumps, contraceptive implants, and inhalation devices. These innovative products offer potential advantages in precision medicine, personalized therapy, and patient convenience, driving advancements in medical treatment and improving patient outcomes across various therapeutic areas.

MARKET DYNAMICS

The rising demand for tailored medicine and targeted therapies drives the development of innovative drug-device combination products that offer precise drug delivery mechanisms and improved patient compliance. As healthcare providers and patients seek more effective and convenient treatment options, there's a rising interest in combination products that combine pharmaceuticals' therapeutic benefits with medical devices' precision and reliability. Additionally, drug formulation technologies and device design advancements enable the development of novel combination products for numerous medical conditions, ranging from chronic diseases to acute conditions. Moreover, regulatory initiatives and guidelines governing combination products, such as the FDA's Combination Product Policy and the EU's Medical Device Regulation (MDR), provide a framework for manufacturers to navigate the complex regulatory landscape and bring innovative products to market.

Furthermore, strategic collaborations between pharmaceutical companies, medical device manufacturers, and research institutions drive innovation and drug-device combination products market expansion, fostering the development of new drug-device combination products across therapeutic areas. Increasing healthcare expenditure and reimbursement support for combination products incentivize investment in research and development, further driving drug-device combination products market growth. However, regulatory hurdles and complexities associated with combination product development and reimbursement challenges may challenge the drug device combination products market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Drug Device Combination Products. The growth and trends of Drug Device Combination Products industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Drug Device Combination Products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents)
• Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps)
• Photodynamic Therapy
• Wound Care Combination Product
• Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes)
• Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons)
• Nebulizers
• Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs))
• Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems)
• Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement)
• Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products)

By Application

• Cardiovascular Disorders
• Diabetes
• Respiratory Problems
• Cancer Treatment
• Antimicrobial Application
• Other

By End-use

• Hospitals And Clinics
• Ambulatory Surgical Centers
• Home Care Settings
• Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Drug Device Combination Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Device Combination Products market include Abbott Laboratories, AbbVie Inc., Alcon Inc., Bausch Health Companies Inc, Baxter International Inc., Bayer AG, Becton, Dickinson And Company, Boston Scientific Corporation, GlaxoSmithKline Plc, Johnson & Johnson, Kaleo Inc., Medtronic Plc, Novartis AG, Sinomed, Smith & Nephew Plc, Teleflex Incorporated, Teva Pharmaceutical Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. DRUG DEVICE COMBINATION PRODUCTS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Drug-Eluting Stents (Coronary Drug-Elating Stents, Peripheral Drug-Eluting Stents) Historic and Forecast Sales By Regions
• 5.4. Infusion Pumps (Implantable Infusion Pumps, Insulin Infusion Pumps, Patient-Controlled Analgesia Pumps, Ambulatory Infusion Pumps, Volumetric Infusion Pumps, Disposable Infusion Pumps) Historic and Forecast Sales By Regions
• 5.5. Photodynamic Therapy Historic and Forecast Sales By Regions
• 5.6. Wound Care Combination Product Historic and Forecast Sales By Regions
• 5.7. Prefilled Syringes (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes) Historic and Forecast Sales By Regions
• 5.8. Drug-Eluting Balloons (Coronary Drug-Eluting Balloons, Peripheral Drug-Eluting Balloons) Historic and Forecast Sales By Regions
• 5.9. Nebulizers Historic and Forecast Sales By Regions
• 5.10. Inhalers (Drug Powdered Inhalers (DPIs), Metered Dose Inhalers (MDIs), Soft Mist Inhalers (SMIs)) Historic and Forecast Sales By Regions
• 5.11. Transdermal Delivery Systems (Active Transdermal Systems, Passive Transdermal Systems) Historic and Forecast Sales By Regions
• 5.12. Orthopedic Combination Products (Bone Graft Implants, Antibiotic Loaded Bone Cement) Historic and Forecast Sales By Regions
• 5.13. Antimicrobial Catheters (Urological Catheters, Cardiovascular Catheters, Other Catheters, Other Products) Historic and Forecast Sales By Regions

6. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Cardiovascular Disorders Historic and Forecast Sales By Regions
• 6.4. Diabetes Historic and Forecast Sales By Regions
• 6.5. Respiratory Problems Historic and Forecast Sales By Regions
• 6.6. Cancer Treatment Historic and Forecast Sales By Regions
• 6.7. Antimicrobial Application Historic and Forecast Sales By Regions
• 6.8. Other Historic and Forecast Sales By Regions

7. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-use
• 7.2. Historical and Forecast Data Analysis By End-use
• 7.3. Hospitals And Clinics Historic and Forecast Sales By Regions
• 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 7.5. Home Care Settings Historic and Forecast Sales By Regions
• 7.6. Other Historic and Forecast Sales By Regions

8. GLOBAL DRUG DEVICE COMBINATION PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DRUG DEVICE COMBINATION PRODUCTS COMPANIES

• 9.1. Drug Device Combination Products Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF DRUG DEVICE COMBINATION PRODUCTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Abbott Laboratories
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. AbbVie Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Alcon Inc.
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Bausch Health Companies Inc
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Baxter International Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Bayer AG
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Becton, Dickinson And Company
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Teva Pharmaceutical Industries Ltd
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Boston Scientific Corporation
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. GlaxoSmithKline Plc
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Johnson & Johnson
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. Kaleo Inc.
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments
• 10.15. Medtronic Plc
  • 10.15.1 Company Overview
  • 10.15.2 Company Revenue
  • 10.15.3 Products
  • 10.15.4 Recent Developments
• 10.16. Novartis AG
  • 10.16.1 Company Overview
  • 10.16.2 Company Revenue
  • 10.16.3 Products
  • 10.16.4 Recent Developments
• 10.17. Sinomed
  • 10.17.1 Company Overview
  • 10.17.2 Company Revenue
  • 10.17.3 Products
  • 10.17.4 Recent Developments
• 10.18. Smith & Nephew Plc
  • 10.18.1 Company Overview
  • 10.18.2 Company Revenue
  • 10.18.3 Products
  • 10.18.4 Recent Developments
• 10.19. Teleflex Incorporated
  • 10.19.1 Company Overview
  • 10.19.2 Company Revenue
  • 10.19.3 Products
  • 10.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies